Buprenorphine initiation in the ER found safe and effectiv e for individuals with opioid use disorder who use fentanyl

Niaid.nih.gov

Click here to subscribe to Niaid.nih.gov

1 year ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Buprenorphine initiation in the ER found safe and effective for individuals with opioid use disorder who use fentanyl 03/30/2023 11:00 AM EDT
With historically high overdose death rates in U.S., multi-site NIH study reinforces importance of continued, uninterrupted access to addiction medication.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Other newsletters from Niaid.nih.gov

Register to Join! NIH World AIDS Day Event Niaid.nih.gov
Yesterday at 20:11
Regstrese para unirse! Evento d el Da Mundial del SIDA de los NIH Niaid.nih.gov
Yesterday at 20:09
Newer epilepsy medications used during pregnancy do not affect neurological development in children Niaid.nih.gov
Yesterday at 16:35

More newsletters from Niaid.nih.gov

Buprenorphine initiation in the ER found safe and effectiv e for individuals with opioid use disorder who use fentanyl

Share on

Other newsletters from Niaid.nih.gov

Related newsletters